Therapeutic studies in hepatic encephalopathy

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Metabolic brain disease

• Publication date

  2007-09-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11011-007-9061-6PMID 17885745
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis.

  2007influential reference
• Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy.

  2007cited by this paper
• Peripheral benzodiazepine receptors in the brain of cirrhosis patients with manifest hepatic encephalopathy

  2006cited by this paper
• Neuropsychological abnormalities in cirrhosis include learning impairment.

  2006cited by this paper
• 232 Critical flicker frequency: Diagnostic tool for minimal hepatic encephalopathy

  2006cited by this paper
• Diabetes Mellitus Is Associated with Hepatic Encephalopathy in Patients with HCV Cirrhosis

  2006cited by this paper
• Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis

  2006cited by this paper
• Brain metabolism of 13N‐ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography

  2006cited by this paper
• Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy

  2006influential reference
• 230 Usefulness of the measurement of critical flicker frequency in the diagnosis of minimal hepatic encephalopathy (MHE)

  2006cited by this paper
• Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy.

  2006influential reference
• 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy.

  2006influential reference
• Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study.

  2005cited by this paper
• Is acarbose an effective drug for treating patients with cirrhosis and hepatic encephalopathy?

  2005cited by this paper
• A randomized controlled trial of acarbose in hepatic encephalopathy.

  2005influential reference
• Attention, Memory, and Cognitive Function in Hepatic Encephalopathy

  2005cited by this paper
• Disruption of smooth pursuit eye movements in cirrhosis: Relationship to hepatic encephalopathy and its treatment

  2005cited by this paper
• Electroencephalographic staging of hepatic encephalopathy by an artificial neural network and an expert system.

  2005cited by this paper
• Impairment of Response Inhibition Precedes Motor Alteration in the Early Stage of Liver Cirrhosis: A Behavioral and Electrophysiological Study

  2005influential reference
• Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey

  2005cited by this paper
• Changes in Brain Size in Hepatic Encephalopathy: A Coregistered MRI Study

  2004cited by this paper
• Characteristics of Minimal Hepatic Encephalopathy

  2004cited by this paper
• Minimal hepatic encephalopathy impairs fitness to drive

  2004cited by this paper
• Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials

  2004cited by this paper
• Treatment of the pruritus of cholestasis

  2004cited by this paper
• Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study

  2004cited by this paper
• Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.

  2003cited by this paper
• Selecting outcome parameters in studies aimed at improving rational use of antibiotics – practical considerations

  2003cited by this paper
• Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis

  2003cited by this paper
• Memory function in early hepatic encephalopathy.

  2003cited by this paper
• Bradykinesia in minimal hepatic encephalopathy is due to disturbances in movement initiation.

  2003influential reference
• Mini-asterixis in hepatic encephalopathy induced by pathologic thalamo-motor-cortical coupling

  2003cited by this paper
• Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy.

  2002cited by this paper
• Critical flicker frequency for quantification of low‐grade hepatic encephalopathy

  2002influential reference
• Correlations Between Cerebral Glucose Metabolism and Neuropsychological Test Performance in Nonalcoholic Cirrhotics

  2002cited by this paper
• Attention Deficits in Minimal Hepatic Encephalopathy

  2001cited by this paper
• Amino acid challenge in patients with cirrhosis: a model for the assessment of treatments for hepatic encephalopathy.

  2001cited by this paper
• Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis.

  2001cited by this paper
• Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients.

  2001cited by this paper
• Neuropsychological characterization of hepatic encephalopathy.

  2001influential reference
• Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium.

  2001cited by this paper
• The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation.

  2001cited by this paper
• Efficacy of Lactulose in Cirrhotic Patients with Subclinical Hepatic Encephalopathy

  2000cited by this paper
• Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests

  1999cited by this paper
• Prognostic significance of hepatic encephalopathy in patients with cirrhosis.

  1999cited by this paper
• Magnetization transfer contrast of various regions of the brain in liver cirrhosis.

  1999cited by this paper
• Spectral versus visual EEG analysis in mild hepatic encephalopathy.

  1999cited by this paper
• Neuropsychological Aspects of Portal-Systemic Encephalopathy

  1998cited by this paper
• Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: An italian multicenter double‐blind, placebo‐controlled, cross‐over study

  1998cited by this paper
• Visual attention in cirrhotic patients: A study on covert visual attention orienting

  1998cited by this paper
• The importance of bacterial infections as precipating factors of chronic hepatic encephalopathy in cirrhosis.

  1998cited by this paper
• Therapeutic efficacy of L‐ornithine‐L‐aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo‐controlled, double‐blind study

  1997influential reference
• Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis.

  1996cited by this paper
• Abnormalities of the Bereitschaftspotential and MRI pallidal signal in non-encephalopathic cirrhotic patients.

  1995cited by this paper
• [Lactulose-neomycin combination versus placebo in the treatment of acute hepatic encephalopathy. Results of a randomized controlled trial].

  1994cited by this paper
• Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy.

  1994cited by this paper
• Reliability of the columbia scale for assessing signs of parkinson's disease

  1993cited by this paper
• Positron‐emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy

  1993cited by this paper
• Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy.

  1992cited by this paper
• Neurophysiological assessment of early hepatic encephalopathy.

  1990influential reference
• Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil.

  1989cited by this paper
• The hepatic coma syndromes and lactulose

  1980cited by this paper
• Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.

  1977cited by this paper
• The electroencephalograph in liver disease.

  1957cited by this paper
• Neomycin in the treatment of hepatic coma.

  1957cited by this paper

• Cinnamaldehyde/lactulose combination therapy alleviates thioacetamide-induced hepatic encephalopathy via targeting P2X7R-mediated NLRP3 inflammasome signaling.

  2024cites this paper
• Babaodan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation.

  2020cites this paper
• Hepatic Encephalopathy

  2019cites this paper
• Hepatic Encephalopathy

  2019cites this paper
• Outcomes in Clinical Trials Evaluating Interventions for the Prevention and Treatment of Hepatic Encephalopathy.

  2019cites this paper
• Consensus Report by the Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees on Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents, Part 3: Focus on Cardiorespiratory Dysfu

  2018cites this paper
• Effects of rifaximin versus nonabsorbable disaccharides in hepatic encephalopathy

  2018cites this paper
• Hepatic encephalopathy

  2016cites this paper
• Diagnosis and Management of Hepatic Encephalopathy in Fulminant Hepatic Failure.

  2015cites this paper
• Future of Hepatic Encephalopathy

  2012cites this paper
• Management of covert hepatic encephalopathy.

  2012cites this paper
• 6 Hepatic Encephalopathy

  2012cites this paper
• Antibiotic Treatment for Hepatic Encephalopathy

  2012cites this paper
• 8. Hepatic Encephalopathy in Patients with Cirrhosis

  2011cites this paper
• Hepatic Encephalopathy in Patients with Cirrhosis

  2011cites this paper
• Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy.

  2011cites this paper
• Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy.

  2011cites this paper
• Management of Hepatic Encephalopathy

  2011cites this paper
• Improving Survival in Patients with Decompensated Cirrhosis

  2011cites this paper
• Hepatic encephalopathy: the role of inflammation, ammonia andaquaporin expression in the pathogenesis of cerebral oedema

  2010cites this paper
• Review article: the modern management of hepatic encephalopathy

  2010cites this paper
• A infecção como factor fisiopatológico de encefalopatia hepática

  2010cites this paper
• Predictors of the recurrence of hepatic encephalopathy in lactulose‐treated patients

  2010cites this paper
• Mechanisms, diagnosis and management of hepatic encephalopathy

  2010cites this paper
• Radiotracer imaging studies in hepatic encephalopathy: ISHEN practice guidelines

  2009cites this paper
• Management options for minimal hepatic encephalopathy

  2008cites this paper